Thalidomide BMS (previously Thalidomide Celgene) Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

thalidomide bms (previously thalidomide celgene)

bristol-myers squibb pharma eeig - thalidomid - multippelt myelom - immunsuppressive - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.

Thalidomide Lipomed Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

thalidomide lipomed

lipomed gmbh - thalidomid - multippelt myelom - immunsuppressive - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.

Topiramat Bluefish 200 mg Norveġja - Norveġiż - Statens legemiddelverk

topiramat bluefish 200 mg

bluefish pharmaceuticals ab - topiramat - tablett, filmdrasjert - 200 mg

Topiramat Bluefish 25 mg Norveġja - Norveġiż - Statens legemiddelverk

topiramat bluefish 25 mg

bluefish pharmaceuticals ab - topiramat - tablett, filmdrasjert - 25 mg

Topiramat Bluefish 50 mg Norveġja - Norveġiż - Statens legemiddelverk

topiramat bluefish 50 mg

bluefish pharmaceuticals ab - topiramat - tablett, filmdrasjert - 50 mg

Topiramat Bluefish 100 mg Norveġja - Norveġiż - Statens legemiddelverk

topiramat bluefish 100 mg

bluefish pharmaceuticals ab - topiramat - tablett, filmdrasjert - 100 mg

Tepadina Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

tepadina

adienne s.r.l. s.u. - tiotepa - hematopoietisk stamcelletransplantasjon - antineoplastiske midler - i kombinasjon med annen kjemoterapi legemidler:med eller uten hele kroppen bestråling (tbi), som condition behandling før allogen eller autologous haematopoietic stamfar cellen transplantasjon (hpct) i haematological sykdommer i voksen og paediatric pasienter, når høy dose kjemoterapi med hpct støtte er aktuelle for behandling av solide svulster hos voksne og paediatric pasienter. det er foreslått at tepadina må forskrives av leger med erfaring i bad behandling før haematopoietic stamfar cellen transplantasjon.

Sumatriptan Bluefish 50 mg Norveġja - Norveġiż - Statens legemiddelverk

sumatriptan bluefish 50 mg

bluefish pharmaceuticals ab - sumatriptansuksinat - tablett - 50 mg

Sumatriptan Bluefish 100 mg Norveġja - Norveġiż - Statens legemiddelverk

sumatriptan bluefish 100 mg

bluefish pharmaceuticals ab - sumatriptansuksinat - tablett - 100 mg

Femostonconti 1 mg / 5 mg Norveġja - Norveġiż - Statens legemiddelverk

femostonconti 1 mg / 5 mg

viatris healthcare ltd. - Østradiolhemihydrat / dydrogesteron - tablett, filmdrasjert - 1 mg / 5 mg